Dr. Meraj Alam
Associate Professor

Ph.D. (Pharmaceutics) – SPER (Jamia Hamdard) – 2017-2024
M.Pharm (Pharmaceutics) – SPER (Jamia Hamdard) – 2013-2015
B. Pharm – SPER (Jamia Hamdard) – 2009-2013
PG-Diploma in Pharmaceutical Drug Regulatory Affair (PGDPRA) – SPER (Jamia Hamdard) – (2013-14)

Message

About

Dr. Meraj is a highly motivated and research-oriented pharmaceutical academician with over 8 years of
experience in pharmaceutical research, teaching, and regulatory affairs. Currently serving as an
Associate Professor at YBN University, he actively contributes to pharmaceutical education and
academic research. His core expertise lies in Nano pharmaceutical formulations and topical drug
delivery systems. He specializes in the design, development, and evaluation of advanced drug delivery
systems and novel pharmaceutical carriers. He has strong knowledge of pharmaceutical technology,
formulation development, and regulatory documentation.
Previously, he worked as a Regulatory Affairs Executive at Evolet Healthcare, gaining valuable industry
experience in compliance and product registration.
He is actively involved in scientific writing, peer review, and scholarly publication activities. He has
reviewed numerous research manuscripts for reputed publishers, including Springer Nature and
Frontiers. He is experienced in mentoring undergraduate and postgraduate students in research
methodology and formulation development. Dr. Meraj is dedicated to advancing pharmaceutical
sciences through innovative research, quality education, and academic excellence

Teaching Areas

Core Courses

Training & Consulting

Research Area

Primary Areas

Current Research Interests

Publications

Journals

  • Alam, M., Rizwanullah, M., Mir, S. R., & Amin, S. (2023). Statistically optimized tacrolimus and thymoquinone co-loaded nanostructured lipid carriers gel for improved topical treatment of psoriasis. Gels, 9(7), 515.
  • Alam, M., Ahmed, S., Nikita, Moon, G., Aqil, M., & Sultana, Y. (2018). Chemical engineering of a lipid nano-scaffold for the solubility enhancement of an antihyperlipidemic drug, simvastatin; preparation, optimization, physicochemical characterization and pharmacodynamic study. Artificial Cells, Nanomedicine, and Biotechnology, 46(8), 1908-1919.
  • Alam, M., Rizwanullah, M., Mir, S. R., & Amin, S. (2023). Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis. OpenNano, 10, 100123.
  • Saifi, Z., Ralli, T., Rizwanullah, M., Alam, M., Vohora, D., Mir, S. R., … & Ameen, S. (2023). BBD Driven Fabrication of Hydroxyapatite Engineered Risedronate Loaded Thiolated Chitosan Nanoparticles and Their In Silico, In Vitro, and Ex Vivo Studies. Micromachines, 14(12), 2182.
  • Rizwanullah, M., Perwez, A., Alam, M., Ahmad, S., Mir, S. R., Rizvi, M. M. A., & Amin, S. (2023). Polymer-lipid hybrid nanoparticles of exemestane for improved oral bioavailability and anti-tumor efficacy: An extensive preclinical investigation. International Journal of Pharmaceutics, 642, 123136.
  • Sartaj, A., Annu, Alam, M., Biswas, L., Yar, M. S., Mir, S. R., … & Ali, J. (2022). Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, and in vivo studies. Journal of Drug Targeting, 30(10), 1113-1134.
  • Rizwanullah, M., Alam, M., Mir, S. R., Rizvi, M., & Amin, S. (2020). Polymer-lipid hybrid nanoparticles: A next-generation nanocarrier for targeted treatment of solid tumors. Current pharmaceutical design, 26(11), 1206-1215.
  • Gilani, S. J., Rizwanullah, M., Imam, S. S., Pandit, J., Aqil, M., Alam, M., & Beg, S. (2019). QbD considerations for topical and transdermal product In Pharmaceutical Quality by Design, 131-150.

Book Chapters

Op-Eds & Columns

Awards

SRF fellowship- CSIR (Govt. of India) – 2019-21
Hamdard National fellowship – 2017-2019
AICTE fellowship (Govt. of India) – 2013-15
eKalyan Scholarship (Govt. of Jharkhand, India) – 2009-13
GPAT Qualified (AIR-428) – 2013
1 st Prize in poster presentation (SGT University; Gurugram, Haryana) – 2023

Education

Ph.D. (Pharmaceutics) – SPER (Jamia Hamdard) – 2017-2024
M.Pharm (Pharmaceutics) – SPER (Jamia Hamdard) – 2013-2015
B. Pharm – SPER (Jamia Hamdard) – 2009-2013
PG-Diploma in Pharmaceutical Drug Regulatory Affair (PGDPRA) – SPER (Jamia Hamdard) – (2013-14)

Research Metrics

09

Publications

276

Citations

7

H-Index
PhD Students